Amdocs (DOX) Stock Price, News & Analysis

Company Overview

Amdocs Limited (NASDAQ: DOX) is a global provider of software and technology services for communications, media and entertainment companies. Its solutions help service providers manage customer relationships, product offerings, billing, ordering, network operations and digital experiences.

The company offers cloud-based and software-as-a-service platforms spanning business and operational support systems, customer experience management, monetization, network automation, data and artificial intelligence. Amdocs also provides consulting, systems integration, application development, modernization and managed services to support the deployment and operation of these technologies.

Amdocs was founded in Israel in 1982 and has grown into an international business serving telecommunications and media companies across North America, Europe, Asia-Pacific and other global markets. The company is headquartered in Chesterfield, Missouri, and is led by Chief Executive Officer Shuky Sheffer.

Key Stats

• Today's Range: $60.15 to $61.65
• 50-Day Range: $50.85 to $63.28
• 52-Week Range: $49.74 to $85.66
• Volume: 605,988 shs
• Average Volume: 1.01 million shs
• Market Capitalization: $6.63 billion
• P/E Ratio: 14.62
• Dividend Yield: 3.70%
• Price Target: $86.67
• Consensus Rating: Hold

Amdocs Stock Analysis - MarketRank™

Amdocs scored higher than 96% of companies evaluated by MarketBeat, and ranked 39th out of 597 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Hold

Consensus Rating

Amdocs has received a consensus rating of Hold. The company's average rating score is 2.29, and is based on no strong buy ratings, 3 buy ratings, 3 hold ratings, and 1 sell rating.

Upside Potential

Amdocs has a consensus price target of $86.67, representing about 41.1% upside from its current price of $61.42.

Amount of Analyst Coverage

Amdocs has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 8.38%

Earnings Growth

Earnings for Amdocs are expected to grow by 8.38% in the coming year, from $6.56 to $7.11 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Amdocs is 14.62, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.17.

Price to Earnings Ratio vs. Sector

The P/E ratio of Amdocs is 14.62, which means that it is trading at a less expensive P/E ratio than the Technology sector average P/E ratio of about 76.62.

Price to Earnings Growth Ratio

Amdocs has a PEG Ratio of 1.05. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Amdocs has a P/B Ratio of 2.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

9.63% of the float of Amdocs has been sold short.

Short Interest Ratio / Days to Cover

Amdocs has a short interest ratio ("days to cover") of 8.

Change versus previous month

Short interest in Amdocs has recently decreased by 12.71%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 5.0 / 5
• Dividend Strength: Strong

Dividend Leadership

Amdocs is a leading dividend payer. It pays a dividend yield of 3.81%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Amdocs has been increasing its dividend for 14 years.

Dividend Coverage

The dividend payout ratio of Amdocs is 54.05%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Amdocs will have a dividend payout ratio of 31.93% next year. This indicates that Amdocs will be able to sustain or increase its dividend.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.71

News Sentiment

Amdocs has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Technology companies.

News Coverage This Week

MarketBeat has tracked 11 news articles for Amdocs this week, compared to 5 articles on an average week.

Search Interest

Only 1 people have searched for DOX on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.

MarketBeat Follows

2 people have added Amdocs to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 1.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Amdocs insiders have not sold or bought any company stock.

Percentage Held by Insiders

15.40% of the stock of Amdocs is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

92.02% of the stock of Amdocs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 7/31 Dividend: 6/30/2026
• Ex-Dividend for 7/31 Dividend: 6/30/2026
• Dividend Payable: 7/31/2026
• Last Earnings: 8/06/2026
• Today: 9/12/2026
• Record date for 10/30 Dividend: 9/30/2026
• Ex-Dividend for 10/30 Dividend: 9/30/2026
• Fiscal Year End: 9/30/2026
• Dividend Payable: 10/30/2026
• Next Earnings (Estimated): 11/10/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Technology
• Industry: IT Services
• Sub-Industry: IT Consulting & Other Services
• Current Symbol: NASDAQ:DOX
• CIK: 1062579
• Web: www.amdocs.com
• Phone: (314) 212-7000
• Fax: 1 314 212 7500
• Employees: 26,969
• Year Founded: 1982

Price Target and Rating

• Average Price Target for Amdocs: $86.67
• High Price Target: $97.00
• Low Price Target: $71.00
• Potential Upside/Downside: +41.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.29
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.20
• Trailing P/E Ratio: 14.62
• Forward P/E Ratio: 9.36
• P/E Growth: 1.05
• Net Income: $564.70 million
• Net Margins: 9.75%
• Pretax Margin: 12.54%
• Return on Equity: 20.28%
• Return on Assets: 10.94%

Debt

• Debt-to-Equity Ratio: 0.23
• Current Ratio: 0.94
• Quick Ratio: 0.94

Sales & Book Value

• Annual Sales: $4.65 billion
• Price / Sales: 1.42
• Cash Flow: $7.99 per share
• Price / Cash Flow: 7.69
• Book Value: $30.74 per share
• Price / Book: 2.00

Miscellaneous

• Outstanding Shares: 107,950,000
• Free Float: 91,326,000
• Market Cap: $6.63 billion
• Optionable: Optionable
• Beta: 0.42